Research graph
References from HPV‐6 Positive Eruptive Verruca Vulgaris After Upadacitinib Initiation for Severe Atopic Dermatitis. Local targets link to admitted publications; unresolved targets remain external evidence.
JAK/STAT Inhibitors for the Treatment of Atopic Dermatitis
10.1080/09546634.2019.1577549 · 2020 · External reference
The Safety of Systemic Janus Kinase Inhibitors in Atopic Dermatitis: A Systematic Review and Network Meta‐Analysis
10.1007/s00228-022-03400-4 · 2022 · External reference
Safety of Upadacitinib in Moderate‐to‐Severe Atopic Dermatitis: An Integrated Analysis of Phase 3 Studies
10.1016/j.jaci.2022.09.023 · 2023 · External reference
Efficacy and Safety of Upadacitinib vs Dupilumab in Adults With Moderate‐to‐Severe Atopic Dermatitis: A Randomized Clinical Trial
10.1001/jamadermatol.2021.3023 · 2021 · External reference
Exacerbation of Human Papillomavirus Infection With Initiation of Upadacitinib for Atopic Dermatitis
10.1016/j.jdcr.2023.04.019 · 2023 · External reference
Occurrence of Extensive Cutaneous Human Papillomavirus Infection After Initiation of Tofacitinib Therapy
10.1001/jamadermatol.2018.5528 · 2019 · External reference
Human Papilloma Virus Type 94–Associated Flat Warts Developing Repeatedly During Tofacitinib Treatment: A Case Report and Review
10.1111/1346-8138.17814 · 2025 · External reference
Development of Multiple Flat Warts During Treatment With Ruxolitinib 1.5% Cream for Non‐Segmental Vitiligo: A Case Report
10.1111/ijd.17963 · 2025 · External reference
Structure–Function of Type I and III Interferons
10.1016/j.coi.2024.102413 · 2024 · External reference
Shared and Distinct Functions of Type I and Type III Interferons
10.1016/j.immuni.2019.03.025 · 2019 · External reference
British Association of Dermatologists' Guidelines for the Management of Cutaneous Warts 2014
10.1111/bjd.13310 · 2014 · External reference
Prophylactic Quadrivalent Human Papillomavirus (Types 6, 11, 16, and 18) L1 Virus‐Like Particle Vaccine in Young Women: A Randomised Double‐Blind Placebo‐Controlled Multicentre Phase Ii Efficacy Trial
10.1016/s1470-2045(05)70101-7 · 2005 · External reference
Prevalence of HPV Genotypes in Adult Male Patients With Cutaneous Warts: A Cross‐Sectional Study
10.1159/000505599 · 2020 · External reference
Epidemiology of Mucosal Human Papillomavirus Infection and Associated Diseases
10.1159/000214920 · 2009 · External reference
10.1016/b978-0-12-814457-2.00010-6
10.1016/b978-0-12-814457-2.00010-6 · 2020 · External reference
Increased Risk of Cutaneous and Systemic Infections in Atopic Dermatitis—A Cohort Study
10.1016/j.jid.2017.01.030 · 2017 · External reference
JAK Inhibitors Remove Innate Immune Barriers Facilitating Viral Propagation
10.1093/narmme/ugaf017 · 2025 · External reference
Risk of Infections During Treatment With Oral Janus Kinase Inhibitors in Randomized Placebo‐Controlled Trials: A Systematic Review and Meta‐Analysis
10.1016/j.jdin.2024.09.012 · 2025 · External reference
